The challenges faced in developing novel drug radiation combinations in non-small cell lung cancer.
Affiliation
Department of Clinical Oncology, Beatson West of Scotland Cancer Centre, GlasgowIssue Date
2016-11
Metadata
Show full item recordAbstract
Lung cancer is the most common cancer diagnosed in the UK. Outcomes for patients with this disease remain poor and new strategies to treat this disease require investigation. One potential option is to combine novel agents with radiotherapy in clinical studies. Here we discuss some of the important issues to consider when combining novel agents with radiotherapy, together with potential solutions as discussed at a recent Clinical Translational Radiotherapy Group (CTRad) workshop.Citation
The challenges faced in developing novel drug radiation combinations in non-small cell lung cancer. 2016, 28(11):720-725 Clin OncolJournal
Clinical OncologyDOI
10.1016/j.clon.2016.08.004PubMed ID
27591000Type
ArticleLanguage
enISSN
1433-2981ae974a485f413a2113503eed53cd6c53
10.1016/j.clon.2016.08.004
Scopus Count
Collections
Related articles
- New radiotherapy and chemoradiotherapy approaches for non-small-cell lung cancer.
- Authors: Salama JK, Vokes EE
- Issue date: 2013 Mar 10
- [Radiochemotherapy in non-small-cell lung cancer].
- Authors: Swartman B
- Issue date: 2011 Nov
- High expression of Rad51c predicts poor prognostic outcome and induces cell resistance to cisplatin and radiation in non-small cell lung cancer.
- Authors: Chen X, Qian D, Cheng J, Guan Y, Zhang B, Ding X, Zeng J, Chen X, Er P, Zhang F, Zhao N, Chen X, Zhao L, Yuan Z, Pang Q, Wang P
- Issue date: 2016 Oct
- Phase II study of vinorelbine plus carboplatin with concurrent radiotherapy in elderly patients with non-small cell lung cancer.
- Authors: Yamaguchi M, Hirata H, Ebi N, Araki J, Seto T, Maruyama R, Akamine S, Inoue Y, Semba H, Sasaki J, Okamoto T
- Issue date: 2020 Mar 9
- Efficacy and safety of recombinant human endostatin during peri-radiotherapy period in advanced non-small-cell lung cancer.
- Authors: Zhu J, Chen G, Niu K, Feng Y, Xie L, Qin S, Wang Z, Li J, Lang S, Zhuo W, Chen Z, Sun J
- Issue date: 2022 Mar